SAFC Pharma, the contract manufacturing arm of Sigma-Aldrich, has
announced it has completed the construction of two protein active
pharmaceutical ingredient (API) facilities at its US manufacturing
site.
Prosonix and Bath University in the UK have won the Royal Society
of Chemistry's (RSC) Innovation award for the development of a tool
that enables the manufacture of crystalline pharmaceuticals of
specific sizes.
A new machine developed by US firm Vardex Laser promises to offer a
unique solution to the global problem of drug counterfeiting,
protecting products right down to the pill itself.
LabTechnologist.com presents its periodic round up of recent
industry news with new developments at Agilent, Beckman Coulter,
Carl Zeiss, DuPont, Luminex and PerkinElmer.
US contract manufacturer PharmaFab has agreed to stop the
manufacturing and distribution of some of its drugs after
regulators found they were produced illegally.
Alpha M.O.S. has recently released an update for its Fox electronic
nose (e-Nose) to provide faster analytical analysis of samples in
R&D, quality control (QC) and process monitoring settings.
Roche gave an update on its manufacturing of influenza drug Tamiflu
(oseltamivir) today, saying that while it had reached its target
capacity of 400 million doses a year, demand is running much lower.
ProBioGen, a specialist in mammalian cell engineering and cell
culture, has entered into two separate agreements to develop
therapeutic proteins with Egyptian drug manufacturer Minapharm..
BioQuate has denied claims that its mainstay device for improving
media throughput and maintaining sterile system integrity in
biotechnology production, infringes on a patent for a rival product
marketed by filtration and separation...
The ever increasing sales of high-voltage field emission
Transmission Electron Microscopes (TEMs) highlights the growing
importance of understanding structure-activity relationships in
structural biology.
Varian has launched a new dissolution system specifically geared to
testing small drug volumes in medical devices such as implants or
drug-eluting stents.
A new method for generating large volumes of therapeutic antibodies
direct from Escherichia coli bacterium could knock weeks
off conventional mass-production processes that scale up to
mammalian cells, US researchers believe.
Applied Biosystems (ABI) and MDS Analytical have released a
first-of-its kind mass spectrometry (MS) platform that they claim
will allow the pharmacokinetic analysis of drug libraries 25 times
faster.
Canadian contract manufacturer Patheon has announced its plans to
restructure its Ontario network of drug manufacturing facilities in
order to improve its profitability.
GE Healthcare has snapped up specialist in disposable manufacturing
technologies Wave Biotech, adding a host of new products and
services for the biopharmaceutical manufacturing sector to its
catalogue.
UK company, deltaDOT is awaiting the completion of its second
production run of its novel high-resolution molecular analyser -
the Peregrine - with over half the batch already sold.
Millipore is launching the first in a line of filtration products
for the biopharmaceutical industry with embedded Radio Frequency
Identification (RFID) technology to facilitate record-keeping and
data transfer in the manufacturing...
A new high pressure microreactor has been developed that increases
chemical reaction rates compared to conventional alternatives -
potentially saving exploratory chemistry labs time and space.
Charles River Laboratories' portable endotoxin testing system, the
Endosafe PTS, has been successfully used to detect bacteria on the
International Space Station (ISS).
Millipore has added a small-volume unit to the NovaSeptum range of
sterile disposable sampling systems it acquired with Swedish
company NovAseptic in July 2005.
Pharmatek has moved to a new larger lab and manufacturing facility
while Pace Analytical Life Sciences recently acquired lab testing
firm P3 Scientific.
A new range of preparative scale supercritical fluid chromatography
(SFC) and extraction (SFE) products promises cheaper and faster
separations and extractions.
Mar Cor Purification has bought GE Water and Process Technologies'
dialysis water business for $30.6m (€22.8m) to become the largest
provider of dialysis water in the US, and plans to expand their
presence in industrial life...
A new millimetre-sized cantilever biosensor has been developed that
can detect cells and proteins at lower levels than ever before even
under flow conditions, opening the way for new biomarker
applications.
US firm Fullscope has announced the availability of a new software
and services package to help pharmaceutical and life science
companies achieve and maintain US Food and Drug Administration
(FDA) validation.
Akorn, a US pharmaceutical company that develops, manufactures and
markets branded and generic diagnostics and therapeutics for niche
segments such as ophthalmology, rheumatology and anaesthesia, has
received a warning letter from...
The first step towards true in-line glucose monitoring for cell
culture bioprocesses has been made that will allow greater control
over the bioprocess manufacturing.
German contract manufacturer Vetter Pharma-Fertigung has been
bestowed with a "facility of the year award" for the processes
employed at its new injectables plant.
GE Healthcare and the Bio Affinity Company (BAC) have extended
their biopharmaceutical partnership to develop purification media
for Factor VIII (FVIII) for the treatment of haemophilia A.
Artel is sending three of their employees to the most extreme
environments in the US to demonstrate the impact of environmental
conditions on pipetted volumes.
Outsourcing is key for pharma companies and medical device
manufacturers keen to develop and produce "combination products" -
medical devices embedded with a pharma component - according to an
industry player.
A Brazilian firm has signed a licensing deal to take advantage of a
biopharmaceutical manufacturing technology which will allow the
company to locally manufacture complex biopharmaceuticals destined
for the South American market.
Both Agilent and Applied Biosystems (ABI) have announced new
facilities in Asia and are looking to gain from the increasing
pharmaceutical industry presence in the region.
Discovery Laboratories has announced that a shareholder lawsuit
filed against the company was dismissed by a Pennsylvania court,
marking the end of its two-year manufacturing nightmare.
